结肠直肠癌的趋势 腹转移研究:全面的图书识别分析
Yuzhe Zhang1, Zi Jin2, Zhongqing Wang3
1The First Laboratory of Cancer Institute, The First Hospital of China Medical University, Shenyang, 110001, China.
Journal of gastrointestinal cancer
|January 23, 2025
概括
结直肠癌腹转移 (CRCPM) 的研究正在增长,美国在出版物方面处于领先地位. 未来的研究将重点关注这种常见转移性癌症的治疗方法和临床试验.
科学领域:
- 在瘤学瘤学.
- 癌症研究 癌症研究
- 转移性疾病 转移性疾病
背景情况:
- 结肠直肠癌 (CRC) 是全球癌症死亡的主要原因.
- 大约50%的CRC患者会发展转移性疾病,腹关闭是常见的.
- 治疗方面的进步改善了结直肠癌腹转移 (CRCPM) 患者的治疗结果.
研究的目的:
- 对目前关于CRCPM的研究进行全面审查.
- 确定该领域的关键趋势,有影响力的贡献者和研究热点.
- 确定CRCPM的未来研究方向.
主要方法:
- 使用R软件 (Bibliometrix套件) 进行文献计量分析.
- 使用CiteSpace和VOSviewer进行数据分析.
- 评估的关键词,作者,国家,机构,文学和期刊.
主要成果:
- 观察到CRCPM出版物的显著增加.
- 美国在研究成果方面处于领先地位,荷兰和法国的贡献显著.
- 伊格纳斯H.J.T.de Hingh是最多产的作者;研究重点是恶性瘤的特征,治疗方法和临床试验.
结论:
- 该研究系统地总结了目前的CRCPM研究,突出了关键领域和未来的趋势.
- 对CRCPM治疗方式的研究正在积极和不断发展.
- 目前正在进行的多中心临床试验有望促进CRCPM的理解和管理.
更多相关视频
11:43Advanced Animal Model of Colorectal Metastasis in Liver: Imaging Techniques and Properties of Metastatic Clones
Published on: November 30, 2016
12.6K
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
11.0K
相关概念视频
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
